Clinical Trial Update: The Safety and Efficacy of Roflumilast Foam in HS [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the safety and efficacy of Roflumilast Foam for hidradenitis suppurativa is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Roflumilast Foam (roflumilast)

Snippet

Sponsor: Beth Israel Deaconess Medical Center | Conditions: Hidradenitis Suppurativa (HS) | Phase 2 | Status: RECRUITING